SG11201505487UA - Enhanced transgene expression and processing - Google Patents
Enhanced transgene expression and processingInfo
- Publication number
- SG11201505487UA SG11201505487UA SG11201505487UA SG11201505487UA SG11201505487UA SG 11201505487U A SG11201505487U A SG 11201505487UA SG 11201505487U A SG11201505487U A SG 11201505487UA SG 11201505487U A SG11201505487U A SG 11201505487UA SG 11201505487U A SG11201505487U A SG 11201505487UA
- Authority
- SG
- Singapore
- Prior art keywords
- processing
- transgene expression
- enhanced transgene
- enhanced
- expression
- Prior art date
Links
- 108700019146 Transgenes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/90—Vectors containing a transposable element
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361759802P | 2013-02-01 | 2013-02-01 | |
| US201361800244P | 2013-03-15 | 2013-03-15 | |
| US201361806634P | 2013-03-29 | 2013-03-29 | |
| PCT/IB2014/000100 WO2014118619A2 (en) | 2013-02-01 | 2014-02-01 | Enhanced transgene expression and processing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201505487UA true SG11201505487UA (en) | 2015-08-28 |
Family
ID=50239688
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201803758XA SG10201803758XA (en) | 2013-02-01 | 2014-02-01 | Enhanced Transgene Expression and Processing |
| SG11201505487UA SG11201505487UA (en) | 2013-02-01 | 2014-02-01 | Enhanced transgene expression and processing |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201803758XA SG10201803758XA (en) | 2013-02-01 | 2014-02-01 | Enhanced Transgene Expression and Processing |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US11898154B2 (zh) |
| EP (2) | EP3536797B1 (zh) |
| JP (1) | JP6563816B2 (zh) |
| KR (1) | KR102235603B1 (zh) |
| CN (1) | CN105073995A (zh) |
| AU (2) | AU2014210856B2 (zh) |
| CA (1) | CA2898878C (zh) |
| DK (2) | DK2951309T3 (zh) |
| ES (2) | ES2940433T3 (zh) |
| FI (1) | FI3536797T3 (zh) |
| HK (1) | HK1216323A1 (zh) |
| HU (2) | HUE043103T2 (zh) |
| IL (1) | IL240198B (zh) |
| LT (1) | LT2951309T (zh) |
| PL (2) | PL3536797T3 (zh) |
| PT (2) | PT3536797T (zh) |
| RU (1) | RU2711505C9 (zh) |
| SG (2) | SG10201803758XA (zh) |
| SI (1) | SI2951309T1 (zh) |
| WO (1) | WO2014118619A2 (zh) |
| ZA (1) | ZA201506419B (zh) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109576265B (zh) * | 2014-04-01 | 2020-08-28 | 三生国健药业（上海）股份有限公司 | 一种含mar核心片段的动物细胞表达载体 |
| CN105154473B (zh) * | 2015-09-30 | 2019-03-01 | 上海细胞治疗研究院 | 一种高效安全的转座子整合系统及其用途 |
| JP6871679B2 (ja) * | 2016-03-23 | 2021-05-12 | 国立大学法人 岡山大学 | 遺伝子発現用カセット及びその産生物 |
| JP2017070224A (ja) * | 2015-10-06 | 2017-04-13 | 国立大学法人 岡山大学 | 遺伝子発現用カセット及びその産生物 |
| US20180265894A1 (en) * | 2015-10-06 | 2018-09-20 | National University Corporation Okayama University | Gene Expression Cassette And Product Thereof |
| CN108473982A (zh) | 2015-12-24 | 2018-08-31 | 思兰克斯有限公司 | 用于蛋白生产的改进的真核细胞及其制备方法 |
| ITUA20161610A1 (it) * | 2016-03-14 | 2017-09-14 | Angela Anna Messina | Composto peptidico farmacologicamente attivo, procedimento per la sua preparazione e suo uso. |
| EP3219800A1 (en) * | 2016-03-15 | 2017-09-20 | Max-Delbrück-Centrum Für Molekulare Medizin | A transposon-based transfection system for primary cells |
| EP3219803A1 (en) * | 2016-03-15 | 2017-09-20 | Max-Delbrück-Centrum für Molekulare Medizin | Enhanced sleeping beauty transposons, kits and methods of transposition |
| KR102536221B1 (ko) * | 2016-05-03 | 2023-05-23 | 론자 리미티드 | 단백질 생산을 위한 지질 대사의 조정 |
| SG10201912370RA (en) | 2016-10-03 | 2020-02-27 | Daiichi Sankyo Co Ltd | PROMOTER OF Hspa5 GENE |
| US11278570B2 (en) | 2016-12-16 | 2022-03-22 | B-Mogen Biotechnologies, Inc. | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods |
| WO2018112415A1 (en) | 2016-12-16 | 2018-06-21 | B-Mogen Biotechnologies, Inc. | ENHANCED hAT FAMILY TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS |
| WO2018224162A1 (en) * | 2017-06-09 | 2018-12-13 | Biontech Rna Pharmaceuticals Gmbh | Methods for characterizing loss of antigen presentation |
| EP3690054A4 (en) * | 2017-09-29 | 2021-07-28 | BethphaGen Inc. | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF HEART FAILURE |
| CN109929839B (zh) * | 2017-12-18 | 2021-02-12 | 华东师范大学 | 拆分型单碱基基因编辑系统及其应用 |
| CN108504692B (zh) * | 2018-03-26 | 2021-07-23 | 安徽大学 | 一种基因敲除cho细胞株的构建方法及其在治疗性重组蛋白表达中的应用 |
| JP7407425B2 (ja) * | 2018-05-18 | 2024-01-04 | ソルボンヌ・ユニヴェルシテ | 導入遺伝子組込みおよびそれらの転位依存性発現のための分子ツールおよび方法 |
| CN112543808A (zh) | 2018-06-21 | 2021-03-23 | 比莫根生物科技公司 | 增强的hAT家族转座子介导的基因转移及相关组合物、系统和方法 |
| RU2686102C1 (ru) * | 2018-08-07 | 2019-04-24 | Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) | Рекомбинантный вектор для создания плазмидных генетических конструкций, обладающих повышенной длительностью экспрессии целевых генов |
| JP2021534807A (ja) * | 2018-09-05 | 2021-12-16 | マックス−デルブリュック−ツェントルム フューア モレキュラーレ メディツィン イン デア ヘルムホルツ−ゲマインシャフト | 合成シス調節ｄｎａを操作する方法 |
| US20210380661A1 (en) * | 2018-10-16 | 2021-12-09 | Texas Tech University System | Method to Express, Purify, and Biotinylate Eukaryotic Cell-Derived Major Histocompatibility Complexes |
| JP2022509451A (ja) | 2018-10-24 | 2022-01-20 | セレキシス エスエー | 発現系、組み換え細胞及びその使用 |
| US20220090144A1 (en) * | 2018-12-24 | 2022-03-24 | Selexis S.A. | Characterization and inactivation of endogenous retroviruses in chinese hamster ovary cells |
| WO2020152532A1 (en) | 2019-01-23 | 2020-07-30 | Enzyvant Therapeutics Gmbh | Method of ameliorating a pro-inflammatory immunophenotype in farber disease subjects by repeated administration of a recombinant human acid ceramidase |
| IT201900002321A1 (it) * | 2019-02-18 | 2020-08-18 | Univ Degli Studi Padova | Peptidi con attivita' antitumorale |
| WO2020198556A2 (en) * | 2019-03-27 | 2020-10-01 | Phoenix Tissue Repair, Inc. | Systems and methods for producing collagen 7 compositions |
| CN110006866B (zh) * | 2019-04-16 | 2022-04-22 | 杭州迈尔德生物科技有限公司 | 一种阿片类活性物质的通用检测方法及其检测试剂盒 |
| WO2020228721A1 (en) * | 2019-05-13 | 2020-11-19 | Lin Mei Chun | Method and kit for monitoring cancer |
| CA3154452A1 (en) * | 2019-10-10 | 2021-04-15 | The Regents Of The University Of California | Methods to stabilize mammalian cells |
| IL270306A (en) | 2019-10-30 | 2021-05-31 | Yeda Res & Dev | Prevention and treatment of pre-myeloid and myeloid malignancies |
| CN110863008B (zh) * | 2019-11-22 | 2020-10-16 | 昆明学院 | Mar序列调控弱启动子构建高效表达载体的方法 |
| WO2021130718A1 (en) | 2019-12-24 | 2021-07-01 | Selexis Sa | Targeted integration in mammalian sequences enhancing gene expression |
| CN115176016A (zh) * | 2020-02-19 | 2022-10-11 | 上海药明生物技术有限公司 | 增强的表达系统及其使用方法 |
| CN111500629B (zh) * | 2020-04-17 | 2021-11-19 | 安徽中盛溯源生物科技有限公司 | 一种高表达层粘连蛋白-511变体的方法及其应用 |
| US20230242936A1 (en) * | 2020-05-14 | 2023-08-03 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Dual promoter systems |
| US20220010332A1 (en) * | 2020-07-08 | 2022-01-13 | Neuracle Genetics Inc. | Intron fragments |
| CN113881703B (zh) * | 2021-10-11 | 2022-06-21 | 中国人民解放军军事科学院军事医学研究院 | 一种提高cho细胞同源重组效率的方法及其相关产品和应用 |
| CN116440269B (zh) * | 2022-01-10 | 2024-02-09 | 华中农业大学 | Slc35a1基因作为靶点在防治猪流行性腹泻病中的应用 |
| CN114958914B (zh) * | 2022-06-06 | 2023-09-26 | 新乡医学院 | 一种人类及哺乳动物细胞附着体表达载体、构建方法和应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5731178A (en) | 1990-03-21 | 1998-03-24 | Behringwerke Aktiengesellschaft | Attachment-elements for stimulation of eukaryotic expression systems |
| JP3656277B2 (ja) * | 1995-05-17 | 2005-06-08 | 味の素株式会社 | 組換えｄｎａ法によるトランスグルタミナーゼの効率的製造法 |
| ES2330201T3 (es) | 2001-01-26 | 2009-12-07 | Selexis S.A. | Regiones de union a la matriz y metodos para el uso de las mismas. |
| US20040235011A1 (en) | 2002-06-26 | 2004-11-25 | Cooper Richard K. | Production of multimeric proteins |
| US20040203158A1 (en) * | 2003-01-15 | 2004-10-14 | Hackett Perry B. | Transposon-insulator element delivery systems |
| US7244616B2 (en) * | 2003-06-27 | 2007-07-17 | Bayer Pharmaceuticals Corporation | Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| AU2004284220B2 (en) | 2003-10-24 | 2010-10-14 | Selexis S.A. | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences |
| ES2292271B1 (es) * | 2004-05-20 | 2009-02-16 | Proyecto De Biomedicina Cima, S.L. | Un vector hibrido adenovirus-alfavirus para la administracion eficaz y expresion de genes terapeuticos en celulas tumorales. |
| EP1899478A2 (en) | 2005-06-10 | 2008-03-19 | Genentech, Inc. | Improving antibody expression using vectors containing insulator elements |
| EP2535419A3 (en) | 2007-09-26 | 2013-05-29 | Intrexon Corporation | Synthetic 5'UTRs, expression vectors, and methods for increasing transgene expression |
| US20090247609A1 (en) | 2007-12-20 | 2009-10-01 | Hitto Kaufmann | Sm-protein based secretion engineering |
| WO2010008564A2 (en) * | 2008-07-16 | 2010-01-21 | Recombinetics | Plaice dna transposon system |
| EP2417263B1 (en) * | 2009-04-09 | 2015-09-23 | ProteoVec Holding L.L.C. | Production of proteins using transposon-based vectors |
| KR20120099376A (ko) * | 2009-09-18 | 2012-09-10 | 셀렉시스 에스. 에이. | 강화된 전이 유전자 발현과 공정 방법 및 그 산물 |
-
2014
- 2014-02-01 DK DK14708935.3T patent/DK2951309T3/en active
- 2014-02-01 PT PT191533769T patent/PT3536797T/pt unknown
- 2014-02-01 PL PL19153376.9T patent/PL3536797T3/pl unknown
- 2014-02-01 EP EP19153376.9A patent/EP3536797B1/en active Active
- 2014-02-01 KR KR1020157022393A patent/KR102235603B1/ko active IP Right Grant
- 2014-02-01 DK DK19153376.9T patent/DK3536797T3/da active
- 2014-02-01 CA CA2898878A patent/CA2898878C/en active Active
- 2014-02-01 RU RU2015127667A patent/RU2711505C9/ru active
- 2014-02-01 SG SG10201803758XA patent/SG10201803758XA/en unknown
- 2014-02-01 AU AU2014210856A patent/AU2014210856B2/en active Active
- 2014-02-01 LT LTEP14708935.3T patent/LT2951309T/lt unknown
- 2014-02-01 ES ES19153376T patent/ES2940433T3/es active Active
- 2014-02-01 HU HUE14708935A patent/HUE043103T2/hu unknown
- 2014-02-01 PT PT14708935T patent/PT2951309T/pt unknown
- 2014-02-01 US US14/761,460 patent/US11898154B2/en active Active
- 2014-02-01 HU HUE19153376A patent/HUE061494T2/hu unknown
- 2014-02-01 FI FIEP19153376.9T patent/FI3536797T3/fi active
- 2014-02-01 PL PL14708935T patent/PL2951309T3/pl unknown
- 2014-02-01 JP JP2015555816A patent/JP6563816B2/ja active Active
- 2014-02-01 CN CN201480010305.9A patent/CN105073995A/zh active Pending
- 2014-02-01 WO PCT/IB2014/000100 patent/WO2014118619A2/en active Application Filing
- 2014-02-01 SG SG11201505487UA patent/SG11201505487UA/en unknown
- 2014-02-01 EP EP14708935.3A patent/EP2951309B1/en active Active
- 2014-02-01 ES ES14708935T patent/ES2717175T3/es active Active
- 2014-02-01 SI SI201431115T patent/SI2951309T1/sl unknown
-
2015
- 2015-07-28 IL IL24019815A patent/IL240198B/en active IP Right Grant
- 2015-09-01 ZA ZA2015/06419A patent/ZA201506419B/en unknown
-
2016
- 2016-04-14 HK HK16104299.2A patent/HK1216323A1/zh unknown
-
2019
- 2019-10-18 AU AU2019250224A patent/AU2019250224B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1216323A1 (zh) | 增强的轉基因表達和加工 | |
| ZA201705571B (en) | Processing materials | |
| GB2524222B (en) | Activating speech processing | |
| GB2516358B (en) | Graphics processing | |
| IL240527B (en) | Composition of dentures and denture system | |
| HUP1300561A2 (en) | Computer architecture and processing | |
| EP2968554A4 (en) | MET BINDER AND USES THEREOF | |
| SG10201800615RA (en) | Form processing | |
| GB201320992D0 (en) | Complex and uses thereof | |
| GB201305361D0 (en) | Enhanced expression | |
| GB201311894D0 (en) | Conveyor and conveyor structure | |
| ZA201601880B (en) | Hetero-transglycosylase and uses thereof | |
| PL3080669T3 (pl) | Układ do obróbki i komponenty do niego | |
| GB201316896D0 (en) | Processing Methods and cassette | |
| GB201301393D0 (en) | Kiddibidet and pottibidet | |
| GB201421001D0 (en) | Materials processing | |
| GB201304166D0 (en) | CelebQuiff and Instant Quiff | |
| GB201321027D0 (en) | Prescribe and treat | |
| GB201312642D0 (en) | Snapaway lead and lure | |
| HU4488U (en) | Plaster-coated and edge-protected chipboard | |
| GB201311534D0 (en) | Concept fifteen | |
| GB201304585D0 (en) | Methods and product |